CoChat

The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis

Yajima, Takahiro, Yajima, Kumiko, Takahashi, Hiroshi, Yasuda, Keigo · 2018 · Journal of Diabetes and its Complications
Cited by 45

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

AIMS To evaluate the effect of dulaglutide on body composition in type 2 diabetes mellitus (T2DM) patients undergoing hemodialysis (HD). METHODS Twenty-one T2DM patients on HD, who had been treated with insulin and newly added teneligliptin (N = 10) or dulaglutide (N = 11), were enrolled. Body composition changes, such as fat mass (FM) and skeletal muscle mass (SMM), glycated albumin (GA), and insulin doses were compared before and after six months of treatment with teneligliptin or dulaglutide. RESULTS The percentage changes of GA and insulin doses were comparable between the teneliglipin and dulaglutide groups. Conversely, although FM and SMM did not change in the teneligliptin group (from 15.7 kg to 14.1 kg, P = 0.63 and 18.6 kg to 18.9 kg, P = 0.16, respectively), those in the dulaglutide group significantly decreased (from 21.9 kg to 18.9 kg, P = 0.037 and 21.0 kg to 20.2 kg, P = 0.011, respectively). CONCLUSIONS Six months of dulaglutide treatment significantly reduced not only FM but also SMM, although changes in GA and insulin doses were comparable with those in the teneligliptin group. Dulaglutide may have the effect of promoting sarcopenia; therefore, it may be carefully used in T2DM patients on HD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jdiacomp.2018.05.018

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 19

  1. Masakane, 2015, An overview of regular dialysis treatment in Japan (as of 31 December 2013), Ther Apher Dial, 19, 540, 10.1111/1744-9987.12378 · DOI · Paper page
  2. United States Renal Data System, 2016, US renal data system 2015 annual data report: epidemiology of kidney disease in the United States, Am J Kidney Dis, 67, S1
  3. Freedman, 2011, Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients, Clin J Am Soc Nephrol, 6, 1635, 10.2215/CJN.11491210 · DOI · Paper page
  4. Isshiki, 2014, Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival, Ther Apher Dial, 18, 434, 10.1111/1744-9987.12123 · DOI
  5. Yajima, 2016, Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis, J Diabetes Complications, 30, 786, 10.1016/j.jdiacomp.2016.02.021 · DOI
  6. Yajima, 2016, Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring, Diabetes Res Clin Pract, 122, 78, 10.1016/j.diabres.2016.10.016 · DOI
  7. Yajima, 2018, Improved glycemic control with once-weekly dulaglutide in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring, J Diabetes Complications, 32, 310, 10.1016/j.jdiacomp.2017.12.005 · DOI
  8. Hong, 2016, Effects of short-term exenatide treatment on regional fat distribution, glycated hemoglobin levels, and aortic pulse wave velocity of obese type 2 diabetes mellitus patients, Endocrinol Metab, 31, 80, 10.3803/EnM.2016.31.1.80 · DOI · Paper page
  9. Rondanelli, 2016, Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus, Patient Prefer Adherence, 10, 407
  10. Noori, 2010, Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease, Semin Dial, 23, 178, 10.1111/j.1525-139X.2010.00705.x · DOI
  11. Kalantar-Zadeh, 2006, Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients, Am J Clin Nutr, 83, 202, 10.1093/ajcn/83.2.202 · DOI · Paper page
  12. Kaysen, 2005, Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy, Am J Clin Nutr, 82, 988, 10.1093/ajcn/82.5.988 · DOI
  13. Yamada, 2008, Simplified nutritional screening tools for patients on maintenance hemodialysis, Am J Clin Nutr, 87, 106, 10.1093/ajcn/87.1.106 · DOI · Paper page
  14. Leenders, 2013, Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging, J Am Med Dir Assoc, 14, 585, 10.1016/j.jamda.2013.02.006 · DOI · Paper page
  15. Kalyani, 2010, Association of diabetes, comorbidities, and A1C with functional disability in older adults, Diabetes Care, 33, 1055, 10.2337/dc09-1597 · DOI · Paper page
  16. Umegaki, 2016, Sarcopenia and frailty in older patients with diabetes mellitus, Geriatr Gerontol Int, 16, 293, 10.1111/ggi.12688 · DOI · Paper page
  17. American Diabetes Association, 2017, Obesity management for the treatment of type 2 diabetes, Diabetes Care, 40, S57, 10.2337/dc17-S010 · DOI
  18. Kato, 2015, Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes, Diabetes Res Clin Pract, 109, 199, 10.1016/j.diabres.2015.04.008 · DOI
  19. Acitores, 2004, Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle, J Endocrinol, 180, 389, 10.1677/joe.0.1800389 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Yajima, T., Yajima, K., Takahashi, H., & Yasuda, K.
Venue
Journal of Diabetes and its Complications
Publisher
Elsevier BV
Published
2018-08
Volume
32
Issue
8
Pages
759-763
ISSN
  • 0891-6632 (ISSN-L)
  • 1056-8727
OpenAlex
W2805267532
Cited by
45
References
7
FWCI
1.02
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis. https://app.cochat.ai/papers/10.1016/j.jdiacomp.2018.05.018
The paper
Yajima, T., Yajima, K., Takahashi, H., & Yasuda, K. (2018). The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis. Journal of Diabetes and its Complications. https://doi.org/10.1016/j.jdiacomp.2018.05.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.